1WIJFFELS M C,KIRCHHOF C J,DORLAND R,et al.Atrial fibrillation begets atrial fibrillation.A study in awake chronically instrumented goats[J].Circulation,1995,92:1954-1968.
2NAKASHIMA H,KUMAGAI K,URATA H,et al.Angiotensin II antagonist prevents electrical remodeling in atrial fibrillation[J].Circulation,2000,101:2612-2617.
3KUMAGAI K,NAKASHIMA H,URATA H,et al.Effects of angiotensin II type 1 receptor antagonist on electrical and structural remodeling in atrial fibrillation[J].J Am Coll Cardiol,2003,41:2197-2204.
4LI D,SHINAGAWA K,PANG L,et al.Effects of angiotensin-converting enzyme inhibition on the development of the atrial fibrillation substrate in dogs with ventricular tachypacing-induced congestive heart failure[J].Circulation,2001,104:2608-2614.
5MORILLO C A,KLEIN G J,JONES D L,et al.Chronic rapid atrial pacing.Structural,functional,and electrophysiological characteristics of a new model of sustained atrial fibrillation[J].Circulation,1995,91:1588-1595.
6WIJFFELS M C,KIRCHHOF C J,DORLAND R,et al.Atrial fibrillation begets atrial fibrillation.A study in awake chronically instrumented goats[J].Circulation.1995.92:1954-1968.
7WILHELM M,KIRSTE W,KULY S,et al.Atrial distribution of connexin 40 and 43 in patients with intermittent,persistent,and postoperative atrial fibrillation[J].Heart Lung Circ,2006,15:30-37.
2COWIE M R, MENDEZ G F. BNP and congesetive heart failure [J]. Curr Probl Cardiol, 2003,28: 264-311.
3BENJAMIN E J,WOKF P A,AGOSTIO R B,et al.Impact of atrial fibrillarion on the risk of death: the Framingham Heart Study[J]. Circulation, 1998, 98:946-952.
4REMMEN W J,SWEDBERG K. European society of cardiology. Comprehensive guidelines for the diagnosis and treartment of the European society of chronic heart failure of the European society of cardiogy [J].Eur J Heart Fail,2Q02,4:11-22.
5Beata Wozakowska-Kapton. Effect of sinus rhythm restoratoin on plasma brain natriuretic peptide in patients with atrial fibrillation[J]. Am J Cardiol,2004,93:1555-1557.
6INOUE S, MURAKAMI Y, SANO K , et al. Atrium as a source of brain natriuretic polypeptide in patients with atrial fibrillation[J]. J Card Failure, 2000,6: 92-93.
7TSUCHIDA K,TANABE K. Influence of paroxysmal atrial fibrillation attack on brain natriuretie peptide secretion[J]. J Cardiol, 2004,44: 1-11.
8JOURDAIN P, BELLORINI M, FUNCK F , et al.Short-term effects of sinus rhythmrestoration in patients with lone atrial fibrillation: a hormonal study[J]. Eur J Heart Fail,2002,4:263-265.
9ROSSI A , ENRIQUEZ-SARANO M, BUMETT J, et al. Natriuretic peptide levels in atrial fibrillation. A prospective hormonal and doppler-echocardiographic study[J]. J Am Coll Cardiol,2000,35: 1256-1257.
10OGAWA Y,ITOH H ,NAKAO K. Molecular biology and biochemistry of natriuretic peptide family[J].Clin Exp Pharmacol Physiol, 1995,22:49- 53.
2Benjamin EJ,Levy D,Vaziri SM,et al. Independent risk factors for atrial fibril- lation in a population-based cohort. The Framingham Heart Study [J]. JAMA, 1994,271(11): 840-844.
5Marcia G, Foard R, Mickiewicz K,et al. 2013 ESH/ESC guidelines for the management of arterial hypertension : The task force for the management of arterial hypertension of the European Society of Hypertension(ESH,) and of the European Society of Cardiology (ESC) [J]. Eur Heart J,2013 [Epub ahead of print].
7Dahlia B, Lindholm LH, Hansson L, et al. Morbidity and mortali- ty in the Swedish Trial in old Patients with Hypertension(STOP- Hypertension) [J]. Lancet, 1991,338 : 1281 - 1285.
8Mensal GA, Croft JB, Giles WH, et al. The heart, kidney, and brain as target organs in hypertension[J]. Cordiol Clin, 2002,20: 225 - 247.
